Clinical Trials Browser

Phase 2 × Completed × ivosidenib × Clear all

NCT03498521 2025-11-19

CUPISCO

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

NCT04056910 2025-02-27

Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors

Phase 2 Completed

15 enrolled 14 charts

Glioma